Enzolytics (PK) Stock Price

0.0005 (0.84%)
Volume 3,057,674
Bid Price 0.0599
Ask Price 0.061
News -
Day High 0.0654


52 Week Range


Day Low 0.059
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Enzolytics Inc (PK) ENZC OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0005 0.84% 0.06 16:30:16
Open Price Low Price High Price Close Price Prev Close
0.059 0.059 0.0654 0.06 0.0595
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
271 3,057,674 $ 0.061223 $ 187,198 - 0.0532 - 0.3195
Last Trade Time Type Quantity Stock Price Currency
15:56:13 3 $ 0.0599 USD


Draw Mode:

Enzolytics Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 169.83M 2.83B -1.98B $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
3.78M $ - - - -

more financials information »

Enzolytics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ENZC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.06970.07180.05320.0623388,977,950-0.0097-13.92%
1 Month0.0760.09880.05320.074642312,179,183-0.016-21.05%
3 Months0.09290.09880.05320.07414718,705,458-0.0329-35.41%
6 Months0.1130.160.05320.089325712,142,056-0.053-46.9%
1 Year0.12650.31950.05320.148128715,839,322-0.0665-52.57%
3 Years0.00150.9580.00010.072873740,943,2670.05853,900.0%
5 Years0.002750.9580.00010.071919529,163,7550.057252,081.82%

Enzolytics (PK) Description

Business Description Enzolytics, Inc. (the "Company" or "ENZC") is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The Company is committed to creating drugs for the better health of mankind. ENZC's flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from major neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.